These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32844230)

  • 1. The microRNA target site landscape is a novel molecular feature associating alternative polyadenylation with immune evasion activity in breast cancer.
    Kim S; Bai Y; Fan Z; Diergaarde B; Tseng GC; Park HJ
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32844230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nudt21 regulates the alternative polyadenylation of Pak1 and is predictive in the prognosis of glioblastoma patients.
    Chu Y; Elrod N; Wang C; Li L; Chen T; Routh A; Xia Z; Li W; Wagner EJ; Ji P
    Oncogene; 2019 May; 38(21):4154-4168. PubMed ID: 30705404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NUDT21 regulates 3'-UTR length and microRNA-mediated gene silencing in hepatocellular carcinoma.
    Sun M; Ding J; Li D; Yang G; Cheng Z; Zhu Q
    Cancer Lett; 2017 Dec; 410():158-168. PubMed ID: 28964783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative polyadenylation of single cells delineates cell types and serves as a prognostic marker in early stage breast cancer.
    Kim N; Chung W; Eum HH; Lee HO; Park WY
    PLoS One; 2019; 14(5):e0217196. PubMed ID: 31100099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression.
    Tan S; Li H; Zhang W; Shao Y; Liu Y; Guan H; Wu J; Kang Y; Zhao J; Yu Q; Gu Y; Ding K; Zhang M; Qian W; Zhu Y; Cai H; Chen C; Lobie PE; Zhao X; Sun J; Zhu T
    Oncogene; 2018 Aug; 37(35):4887-4900. PubMed ID: 29780166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissecting the heterogeneity of the alternative polyadenylation profiles in triple-negative breast cancers.
    Wang L; Lang GT; Xue MZ; Yang L; Chen L; Yao L; Li XG; Wang P; Hu X; Shao ZM
    Theranostics; 2020; 10(23):10531-10547. PubMed ID: 32929364
    [No Abstract]   [Full Text] [Related]  

  • 7. Transforming growth factor β1 alters the 3'-UTR of mRNA to promote lung fibrosis.
    Ko J; Mills T; Huang J; Chen NY; Mertens TCJ; Collum SD; Lee G; Xiang Y; Han L; Zhou Y; Lee CG; Elias JA; Jyothula SSK; Rajagopal K; Karmouty-Quintana H; Blackburn MR
    J Biol Chem; 2019 Oct; 294(43):15781-15794. PubMed ID: 31488543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
    Huang J; Weng T; Ko J; Chen NY; Xiang Y; Volcik K; Han L; Blackburn MR; Lu X
    Biochem Biophys Res Commun; 2018 Sep; 503(2):856-862. PubMed ID: 29928883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative polyadenylation drives oncogenic gene expression in pancreatic ductal adenocarcinoma.
    Venkat S; Tisdale AA; Schwarz JR; Alahmari AA; Maurer HC; Olive KP; Eng KH; Feigin ME
    Genome Res; 2020 Mar; 30(3):347-360. PubMed ID: 32029502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of NUDT21 in microRNA-binging sites of EZH2 gene increases the of risk preeclampsia.
    Lang X; Zhao W; Huang D; Liu W; Shen H; Xu L; Xu S; Huang Y; Cheng W
    J Cell Mol Med; 2019 May; 23(5):3202-3213. PubMed ID: 30883033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent tumor-specific regulation of alternative polyadenylation of cancer-related genes.
    Xue Z; Warren RL; Gibb EA; MacMillan D; Wong J; Chiu R; Hammond SA; Yang C; Nip KM; Ennis CA; Hahn A; Reynolds S; Birol I
    BMC Genomics; 2018 Jul; 19(1):536. PubMed ID: 30005633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reprogramming of 3' untranslated regions of mRNAs by alternative polyadenylation in generation of pluripotent stem cells from different cell types.
    Ji Z; Tian B
    PLoS One; 2009 Dec; 4(12):e8419. PubMed ID: 20037631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NUDT21 inhibits bladder cancer progression through ANXA2 and LIMK2 by alternative polyadenylation.
    Xiong M; Chen L; Zhou L; Ding Y; Kazobinka G; Chen Z; Hou T
    Theranostics; 2019; 9(24):7156-7167. PubMed ID: 31695759
    [No Abstract]   [Full Text] [Related]  

  • 14. NUDT21 alters glioma migration through differential alternative polyadenylation of LAMC1.
    Jonnakuti VS; Ji P; Gao Y; Lin A; Chu Y; Elrod N; Huang KL; Li W; Yalamanchili HK; Wagner EJ
    J Neurooncol; 2023 Jul; 163(3):623-634. PubMed ID: 37389756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential genome-wide profiling of tandem 3' UTRs among human breast cancer and normal cells by high-throughput sequencing.
    Fu Y; Sun Y; Li Y; Li J; Rao X; Chen C; Xu A
    Genome Res; 2011 May; 21(5):741-7. PubMed ID: 21474764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of untranslated region alternative polyadenylation in glioma tumorigenesis.
    Lan YL; Zhang J
    Biomed Pharmacother; 2021 May; 137():111416. PubMed ID: 33761620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential microRNA regulation correlates with alternative polyadenylation pattern between breast cancer and normal cells.
    Liaw HH; Lin CC; Juan HF; Huang HC
    PLoS One; 2013; 8(2):e56958. PubMed ID: 23437281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3'-UTR landscape across seven tumour types.
    Xia Z; Donehower LA; Cooper TA; Neilson JR; Wheeler DA; Wagner EJ; Li W
    Nat Commun; 2014 Nov; 5():5274. PubMed ID: 25409906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CPSF3 regulates alternative polyadenylation of CNIH2 to promote esophageal squamous cell carcinoma progression.
    Zhang Y; Liu D; Guo D; Lin W; Lu W; Hu L; Chen S; Chen C
    Cancer Lett; 2024 Jul; 593():216925. PubMed ID: 38718887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of polyadenylation in health and disease.
    Curinha A; Oliveira Braz S; Pereira-Castro I; Cruz A; Moreira A
    Nucleus; 2014; 5(6):508-19. PubMed ID: 25484187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.